Improving the treatment of hepatitis C infection in the UK.
The UK lags behind its European neighbours in the identification and treatment of hepatitis C virus infection. Having recognised this problem, national guidelines are evolving based on detailed examination of clinical evidence. This article reviews recommended treatments for hepatitis C virus infection in the UK, recent advances in the understanding of how to use these treatments and new developments.
Cooke
Graham S
GS
Academic Department of Medicine, St Mary's Hospital, Level 10, QEQM Building, London W2 1NY, UK. graham.cooke@st-marys.nhs.uk
Main
Janice
J
D000208:Acute Disease; D000410:Alanine Transaminase / Q000097:blood; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005838:Genotype; D016174:Hepacivirus / Q000145:classification; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000635:transmission; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D016031:Liver Transplantation; D018579:Patient Selection; D017211:Treatment Failure
D000998:Antiviral Agents; D000410:Alanine Transaminase